Elastic NV vs Medtronic PLC — how do they compare? Elastic NV trades at $62.79 (market cap $6.47B), while Medtronic PLC trades at $83.27 (market cap $103.01B). The key difference: Medtronic PLC is far larger — about 15.9× Elastic NV's market cap, and Medtronic PLC pays a 3.58% dividend while Elastic NV pays none. Which is the better fit depends on your goals.
| ESTC | MDT | |
|---|---|---|
Market Cap | $6.47B | $103.01B |
Sector | Technology | Health |
52-Week High | $94.47 | $105.35 |
52-Week Low | $43.30 | $73.75 |
Enterprise Value | $5.69B | $121.75B |
Dividend Yield | — | 3.58% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Medtronic (MDT) trades at $83.19, up 4.91% over the past 24 hours, with a technical outlook that is bearish based on moving averages but supported by neutral oscillators. The stock has consistently beaten earnings expectations in recent quarters, with Q1 2026 EPS of $1.55 surpassing the $1.54 estimate. Revenue grew to $33.54 billion in 2025, and the company maintains strong profitability with a net income margin of 13.2%. Recent corporate actions include a $0.72 dividend payment scheduled for July 2026.
The outlook for MDT is positive, supported by robust fundamentals, a favorable analyst consensus with a $97.50 price target, and a dividend aristocrat status. Key risks include increasing debt levels and competitive pressures in the medical device sector. The stock presents a long-term opportunity for growth and income, though near-term technical weakness may persist.
Trailing returns across standard periods
Latest headlines on both assets
Elastic NV provides a leading search AI platform built on Elasticsearch. Its software helps organizations find, observe, and protect data through search-powered analytics for various cloud-based applications.
Read more on ESTC →One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →